Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perspectives on cancer prevention

L Garfinkel

    CA: a Cancer Journal for Clinicians
    |January 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Reducing cancer risk is key to controlling cancer. Accumulated evidence suggests authoritative groups should consider recommending chemopreventive substances for cancer prevention.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Changes in the bronchial epithelium in relation to the tobacco habit and to carcinoma of the lung].

    Revista mexicana de tuberculosis y enfermedades del aparato respiratorio·2014
    Same author

    U.S. cancer incidence, mortality and survival: 1973-1996.

    Statistical bulletin (Metropolitan Life Insurance Company : 1984)·1999
    Same author

    Mortality hazard associated with prescription hypnotics.

    Biological psychiatry·1998
    Same author

    Trends in cigarette smoking in the United States.

    Preventive medicine·1997
    Same author

    Oscar Auerbach, M.D.: in memoriam.

    Cancer·1997
    Same author

    Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project.

    CA: a cancer journal for clinicians·1997
    Same journal

    Serious mental illness and cancer: A call to action for equitable care.

    CA: a cancer journal for clinicians·2026
    Same journal

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same journal

    Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

    CA: a cancer journal for clinicians·2026
    Same journal

    Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

    CA: a cancer journal for clinicians·2026
    See all related articles

    Area of Science:

    • Oncology
    • Epidemiology
    • Preventive Medicine

    Background:

    • Cancer control strategies increasingly focus on risk reduction.
    • Ongoing research explores effective methods for preventing cancer development.

    Discussion:

    • The accumulation of evidence supports the proactive use of chemopreventive agents.
    • Expert bodies should evaluate and potentially recommend specific substances for cancer risk reduction.

    Key Insights:

    • Chemoprevention offers a promising avenue for proactive cancer risk management.
    • Translating research findings into public health recommendations is crucial.

    Outlook:

    • Future research should continue to identify and validate safe and effective chemopreventive agents.
  • Wider adoption of evidence-based recommendations can significantly impact cancer incidence rates.